1. Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up. (2nd January 2019) Authors: Wang, Rui; Smyth, Lillian M.; Iyengar, Neil; Chandarlapaty, Sarat; Modi, Shanu; Jochelson, Maxine; Patil, Sujata; Norton, Larry; Hudis, Clifford A.; Dang, Chau T. Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: e646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reply to Tagliafico AS, Bignotti B, Rossi F, et al. (April 2017) Authors: Jochelson, Maxine; Lobbes, Marc B.I.; Bernard-Davila, Blanca Journal: Breast Issue: Volume 32(2017) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to the "Letter to the Editor" by Dr. Thomas Filleron. Issue 2 (5th March 2013) Authors: Moskowitz, Chaya S.; Zabor, Emily C.; Jochelson, Maxine Journal: Breast journal Issue: Volume 19:Issue 2(2013:Mar./Apr.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗